RESOURCES
Items 133-144 of 144 Results
-
Discover our custom solutions
The best product is the one tailored to your needs! Regardless of your organization’s size, the stage of your research or specialized needs, we offer a broad range of customization. -
Serum- and xeno-free culture of human CD34+ hematopoietic progenitor cells (HPCs)
Learn how defined, serum- and xeno-free culture systems can overcome the most common challenges in CD34+ HPC expansion. -
Other species and cell types compatible with PromoCell adult stem & stromal cell media
A compiled list of publications in which our various adult stem and stromal cell culture media have been applied to different species or cell types. -
3D tumorsphere cell culture model
Explore a matrix-free tumorsphere system that's designed to support cancer stem cells and enable robust 3D culture from almost any starting material. -
Other species and cell types compatible with PromoCell blood cell media
A compiled list of publications in which our various blood cell culture media have been applied to different species or cell types. -
Other species and cell types compatible with PromoCell muscle cell media
A compiled list of publications in which our various muscle cell culture media have been applied to different species or cell types. -
Expansion of primitive hematopoietic progenitor cells
Researchers often face challenges in expanding primitive hematopoietic stem and progenitor cells while maintaining their undifferentiated state. Our Hematopoietic Progenitor Cell (HPC) Expansion Medium XF provides a highly optimized, xeno-free culture system designed for robust expansion and reliable preservation of the CD34⁺ progenitor population, with options suitable for translational and GMP-compatible workflows. -
Modeling the esophageal adenocarcinoma microenvironment within a cancer-on-chip platform
Discover how to use 3D Tumorsphere Medium XF on the MIVO® cancer-on-chip platform to culture esophageal cancer spheroids, and create more physiologically relevant cancer models. -
Pilot Evaluation Batch program
Our Pilot Evaluation Batch (PEB) program is a pilot-scale media manufacturing service designed to act as a bridge to Excipient GMP-grade media. -
Laying the foundations for a robust stem cell workflow
Learn how early process decisions can improve robustness, scalability, and reproducibility in stem cell therapy development in this RegMedNet interview featuring our expert Hagen Wieland. -
Stem cell therapy - Building reproducible and scalable workflows
Learn how to reduce variability and support successful translation in stem cell therapy development with our infographic on stem cell workflows. -
Adoptive cell therapies: advancing cancer treatment for solid tumors
Discover the latest insights and strategies shaping the future of cancer treatment.